DNP63A GENE AND SCREENING METHODS OF ANTICANCER AGENT BY USING IT
    9.
    发明申请
    DNP63A GENE AND SCREENING METHODS OF ANTICANCER AGENT BY USING IT 审中-公开
    DNP63A基因和使用它的抗病毒剂筛选方法

    公开(公告)号:WO2008120831A1

    公开(公告)日:2008-10-09

    申请号:PCT/KR2007/001576

    申请日:2007-03-30

    Abstract: This invention relates to a gene encoding ΔNp63 α and screening methods of anticancer-drugs thereof, more specifically a gene encoding ΔNp63 α and a protein which is transported from nucleus to cytoplasm by contacting with potential anticancer-drugs in an epithelial cell carcinoma, a recombinant vector comprising said gene and reporter genes, and carcinoma cells comprising said vector. Also, This invention relates to high throughput screening methods of anticancer-drug comprising identifying the transportation of ΔNp63 α protein from nucleus to cytoplasm by contacting with potential anticancer-drug in a carcinoma cell.

    Abstract translation: 本发明涉及编码αNp63a的基因及其抗癌药的筛选方法,更具体地说,涉及编码αNp63a的基因和通过与上皮细胞癌中的潜在抗癌药物接触从细胞核转运至细胞质的蛋白质, 包含所述基因和报告基因的重组载体,以及包含所述载体的癌细胞。 此外,本发明涉及抗癌药物的高通量筛选方法,其包括通过与癌细胞中的潜在抗癌药物接触来鉴定蛋白质从核到蛋白质的转运。

Patent Agency Ranking